Type of Study:
Trial evaluates 2 dose schedules for Semaglutide and the new pen-injector . Patients can not be taking Ozempic or insulin.
over 18 years, Male and Female
Participants will receive at no cost: study product, study materials and study-specific procedures
The Sustain Switch trial compares the effect and safety of 2 different dose schedules for semaglutide (study medicine) in people with type 2 diabetes previously treated with a diabetes medicine similar to semaglutide.